fig8

Reversal of doxorubicin resistance in lung cancer cells by neferine is explained by nuclear factor erythroid-derived 2-like 2 mediated lung resistance protein down regulation

Figure 8. In silico analysis of LRP promoter sequence: 1.5 kb promoter region of LRP region was retrieved from Ensembl database (www.ensembl.org) and putative NRF2 binding sites were predicted (consite.genereg.net) as indicated. A: lung resistance protein or major vault protein - 1.5 kb promoter region; B: putative transcription factor binding sites found along LRP promoter. Sequences highlighted in blue show NRF2 binding sites as predicted by ConSite and +1 indicates the transcriptional start site. NRF2: nuclear factor erythroid-derived 2-like 2; LRP: lung resistance protein

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/